Skip to main content
Log in

Matrix metalloproteinase-2 and-9 expression in astrocytic tumors

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

In this study, we investigated whether the expression of matrix metalloproteinase (MMP)-2 and MMP-9 correlated with invasiveness, proliferative potential, or prognosis in astrocytic tumors. Thirty-seven astrocytic tumors (8 diffuse astrocytomas, 15 anaplastic astrocytomas, and 14 glioblastomas) and three gliomatosis cerebri were investigated immunohistochemically. The invasive glioma group included three cases of gliomatosis cerebri and two of glioblastoma associated with cerebrospinal fluid dissemination. The expression of MMP-2 and MMP-9 was evaluated by assigning an immunohistochemical (IHC) score defined as the sum of expression frequency and intensity. mRNA expression patterns for the MMPs were also evaluated in a reverse transcription-polymerase chain reaction assay. Neither the MMP-2 nor MMP-9 IHC score was related to histological malignancy. The MMP-2 IHC score of the invasive glioma group was significantly higher than those of other kinds of astrocytic tumors. However, the MMP-9 IHC score did not correlate with dissemination among astrocytic tumors. An inverse correlation was observed between the MIB-1 labeling index and the IHC scores of MMP-2, but it was not significant. A Kaplan-Meyer survival analysis revealed no significant relationship between the survival rate and MMP-2 or MMP-9 expression. Our study showed that MMP-2 expression, but not MMP-9 expression, may be associated with invasion in astrocytic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chintala SK, Tonn JC, Rao JS (1999) Matrix metalloproteinases and their biological function in human gliomas. Int J Dev Neurosci 17:495–502

    Article  PubMed  CAS  Google Scholar 

  2. Duffy MJ, McCarthy K (1998) Matrix metalloproteinases in cancer: prognostic markers and targets for therapy. Int J Oncol 12: 1343–1348

    PubMed  CAS  Google Scholar 

  3. Forsyth PA, Wong H, Laing Td, et al. (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79:1828–1835

    Article  PubMed  CAS  Google Scholar 

  4. Ulm JH, Dooley NP, Villemure JG, et al. (1997) Glioma invasion in vitro: regulation by matrix metalloproteinase-2 and protein kinase C. Clin Exp Metastasis 14:421–433

    Google Scholar 

  5. Giese M, Westphal M (1996) Glioma invasion in the central nervous system. Neurosurgery 39:235–250

    Article  PubMed  CAS  Google Scholar 

  6. Nakano A, Tani E, Miyazaki K, et al. (1995) Matrix metallo-proteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298–307

    PubMed  CAS  Google Scholar 

  7. Pilkington GJ (1994) Tumor cell migration in the central nervous system. Brain Pathol 4:157–166

    PubMed  CAS  Google Scholar 

  8. Kunishio K, Morisaki K, Kawai N, et al. (1998) Analysis of intraoperative radiotherapy for malignant gliomas. Neuro-Oncology 8:21–27

    Google Scholar 

  9. Nakagawa T, Kubota T, Kabuto M, et al. (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81:69–77

    PubMed  CAS  Google Scholar 

  10. Sawaya RE, Yamamoto M, Gokaslan ZL, et al. (1996) Expression and localization of 72-kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35–42

    Article  PubMed  CAS  Google Scholar 

  11. Nakada M, Nakamura H, Ikeda E, et al. (1999) Expression and tissue localization of membrane-type 1, 2, and 3 matrix metallo-proteinases in human astrocytic tumors. Am J Pathol 154:417–428

    PubMed  CAS  Google Scholar 

  12. Jaalinoja J, Herva R, Korpela M, et al. (2000) Matrix metallo-proteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms. J Neurooncol 46:8190

    Article  Google Scholar 

  13. Thier M, Roeb E, Breuer B, et al. (2000) Expression of matrix metalloproteinase-2 in glial and neural tumor cell lines: inverse correlation with proliferation rate. Cancer Lett 149:163–170

    Article  PubMed  CAS  Google Scholar 

  14. Wild-Bode C, Weller M, Wick W (2001) Molecular determinants of glioma cell migration and invasion. J Neurosurg 94:978–984

    Article  PubMed  CAS  Google Scholar 

  15. Beliveau R, Delbecchi L, Beaulieu E, et al. (1999) Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Ann N Y Acad Sci 886:236–239

    Article  PubMed  CAS  Google Scholar 

  16. Nakada M, Kita D, Futami K, et al. (2001) Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metallo-proteinase 2 in invasion and dissemination of human malignant glioma. J Neurosurg 94:464–473

    Article  PubMed  CAS  Google Scholar 

  17. Takano S, Tsuboi K, Matsumura A, et al. (2001) Localization of gelatinase activities in glioma tissues by film in situ zymography. Brain Tumor Pathol 18:145–150

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katsuzo Kunishio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kunishio, K., Okada, M., Matsumoto, Y. et al. Matrix metalloproteinase-2 and-9 expression in astrocytic tumors. Brain Tumor Pathol 20, 39–45 (2003). https://doi.org/10.1007/BF02483445

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02483445

Key words

Navigation